RGDFAP: platelet aggregation inhibitory and profibrinolytic hybrid peptide (RGDF coupled with the carboxy terminal part of alpha 2-antiplasmin) enhances plasminogen binding to platelets.

Source:http://linkedlifedata.com/resource/pubmed/id/8589217

Download in:

View as

General Info

PMID
8589217